Cargando…
COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a century. In 11 months since its first emergence, according to WHO, the causative infectious agent SARS‐CoV‐2 has infected more than 100 million people and claimed more than 2.15 million lives worldwide. Moreover,...
Autores principales: | Singh, Ramandeep, Kang, Alisha, Luo, Xiangqian, Jeyanathan, Mangalakumari, Gillgrass, Amy, Afkhami, Sam, Xing, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898934/ https://www.ncbi.nlm.nih.gov/pubmed/33577115 http://dx.doi.org/10.1096/fj.202002662R |
Ejemplares similares
-
Adenoviral-vectored next-generation respiratory mucosal
vaccines against COVID-19
por: Afkhami, Sam, et al.
Publicado: (2023) -
Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020) -
Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung
por: Kang, Alisha, et al.
Publicado: (2023) -
Immunological considerations for COVID-19 vaccine strategies
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2020) -
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015)